MoonLake Immunotherapeutics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$19
$19
Gross Profit
-28
-22
16
EBITDA
-43,079
-30,550
-19,797
-15,025
EBIT
-43,112
-30,578
-19,820
-15,028
Net Income
-35,930
-24,267
-13,673
-7,437
Net Change In Cash
0
0
19
19
Free Cash Flow
-25,407
-27,890
-15,160
-12,628
Cash
375,656
342,791
458,441
451,169
Basic Shares
62,896
62,874
62,637
59,914

Annual Financials

Values in thousands 2023-12-31 2022-12-31
Revenue
$0
$0
Gross Profit
-13
-12
EBITDA
-54,109
-65,049
EBIT
-54,123
-65,061
Net Income
-36,007
-64,506
Net Change In Cash
0
0
Cost of Revenue
31,458
Free Cash Flow
-43,062
-55,909
Cash
451,169
39,505
Basic Shares
49,122
29,361

Earnings Calls

Quarter EPS
2024-09-30
-$0.56
2024-06-30
-$0.39
2024-03-31
-$0.22
2023-12-31
-$0.12